Skip to content
Wearables & measurementOverview of reviews5 min read

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses · The Lancet Digital Health · 2022 · Original paper ↗

Key takeaway

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

Study design

Overview of reviews

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Physical inactivity is a widespread health problem, and wearable activity trackers are an appealing, low-cost tool to address it. Separate reviews and meta-analyses have looked at trackers in different groups of people and for different outcomes. The authors gathered them into one umbrella review, a systematic review of systematic reviews, to ask whether trackers improve physical activity and related physiological and psychosocial outcomes, in clinical and non-clinical populations alike.

Who and how

This is a systematic review of systematic reviews and meta-analyses. The authors searched seven databases (Embase, MEDLINE, Ovid Emcare, Scopus, SPORTDiscus, the Cochrane Library and Web of Science) from their inception to April 8, 2021. Eligible reviews summarized primary studies that used activity trackers as interventions and reported physical activity, physiological or psychosocial outcomes. The search identified 39 systematic reviews and meta-analyses, together reporting results from 163,992 participants of all age groups, healthy and clinical.

The abstract reports the pooled results as ranges of standardised mean differences (SMD), which put outcomes measured in different units on one scale, and translates them into steps, minutes of walking and kilograms. Full details are not in the abstract: it does not give the number of primary studies or trials behind the 39 reviews, say whether they were randomised, describe how study quality was rated or how overlapping studies were handled, or report follow-up times, confidence intervals or P values.

What it found

  1. 1
    Trackers were associated with more physical activity. The meta-analyses suggested an SMD of 0.3–0.6 for physical activity, which the authors translate into approximately 1,800 extra steps per day and 40 minutes per day more walking.
  2. 2
    Body composition and fitness also improved. Pooled SMDs were 0.7–2.0 for body composition and 0.3 for fitness, and the authors equate the body composition result to reductions of approximately 1 kg in bodyweight. The wide SMD range for body composition suggests the reviews did not agree closely on its size.
  3. 3
    Other health markers moved little. Effects for blood pressure, cholesterol and glycosylated haemoglobin, and for quality of life and pain, were typically small and often non-significant, so the step gain should not be assumed to carry over into these outcomes.
  4. 4
    The authors conclude that trackers appear effective at increasing physical activity across age groups and in clinical and non-clinical populations, that the benefit is clinically important and sustained over time, and that there is sufficient evidence to recommend their use. The abstract gives no follow-up durations to back up the claim of a sustained effect.

Limits & uncertainty

  1. 1
    Our observation: an umbrella review summarizes other reviews, not raw trial data, and the abstract gives only SMD ranges. There are no confidence intervals, P values or counts of primary studies, so the certainty of each estimate cannot be judged from it.
  2. 2
    Our observation: the studies tested trackers as part of interventions, and the abstract does not say what else was included, such as goals, feedback or coaching. Being given a tracker in a program is not the same as buying one on your own, so the average gain may not apply to an unsupported purchase.
  3. 3
    Our observation: the abstract does not say how overlap between reviews, which can count the same primary study more than once, was handled. The wide ranges, such as an SMD of 0.7–2.0 for body composition, point to substantial variation between reviews, populations and trackers.
  4. 4
    Our observation: the step, walking-time and weight equivalents are described as approximate, and the abstract does not say how the SMDs were converted into them. This reading is based on the abstract only, so details of study quality and programs are not covered.

What to take from it

Across a large body of research, using a tracker as part of a program was associated with a rise in daily movement, on the order of 1,800 steps or 40 minutes of walking, and with a small drop in weight of about 1 kg. A tracker can be a useful nudge when it comes with a clear goal and feedback, but the review does not show that it moves blood pressure, cholesterol, glycosylated haemoglobin, quality of life or pain.

Do not conclude that buying a tracker on its own produces these gains, that they will apply to any one person, or that a tracker can stand in for treatment of blood pressure, cholesterol or diabetes; those decisions belong with a clinician. The authors call the evidence sufficient to recommend trackers, but with only the abstract available this is encouraging evidence on average, not a guarantee.

Reading your own data

Take your own baseline first: average daily steps with the same device over a normal couple of weeks, then change one habit and compare the same measure afterwards. Count days you did not wear the device as missing, not as zero. Step counts and active minutes from different devices or apps are not interchangeable, so keep to one source for the comparison and note any app or firmware change.

How to read this evidence

Reviews may reuse the same trials. Review counts are not independent replications; study quality, overlap and outcome-specific certainty matter.

Sources & attribution

Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses

The Lancet Digital Health · 2022-08

DOI: 10.1016/S2589-7500(22)00111-X ↗PubMed · 35868813 ↗

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
·Validation study/review

Seven wrist devices: heart rate mostly within 5% error, calorie estimates far off

Sixty adults wore seven wrist-worn devices while sitting, walking, running and cycling in a laboratory. Median heart rate error against an electrocardiogram (ECG) ran from 1.8% on the bike to 5.5% walking, but no device achieved a calorie error below 20 percent (device medians from 27.4% to 92.6%). These were consumer models on sale at the time, tested in a lab, so the results do not rank today's watches or show how they perform in daily life.

Journal of Personalized Medicine

In-depth explainersRead study →
Wearables & measurement →